2025-11-17T17:47:22-06:00 2024-12-31 WITHUMSMITHBROWN PC 1411 BROADWAY 9TH FLOOR NEW YORK NY 10018 990 2024-01-01 473290570 Global Alzheimer's Platform Foundation Inc % THE ORGANIZATION GLOB 3014522111 1930 18th St NW Suite B2 1017 Washington DC 20009 JOHN DWYER PRESIDENT 3014522111 2025-03-12 true true Israel Tannenbaum CPA P01589203 2127519100 2024 2025-03-06 01:10:19Z X JOHN DWYER 1101 K STREET NW SUITE 400 Washington DC 20009 6540423 false X www.globalalzplatform.org X 2015 DC WE ARE A PATIENT-CENTRIC, NON-PROFIT ORGANIZATION DEDICATED TO SPEEDING THE DELIVERY OF INNOVATIVE THERAPIES TO THOSE LIVING WITH ALZHEIMER'S BY REDUCING THE TIME AND COST OF ALZHEIMER'S DISEASE (AD) CLINICAL TRIALS. 6 6 60 0 0 0 1008279 308735 7571850 6213316 114871 57 0 18315 8695000 6540423 0 21382 0 0 5017942 3782251 0 0 0 6656338 6775695 11674280 10579328 -2979280 -4038905 4247190 3543018 835651 4170384 3411539 -627366 X GLOBAL ALZHEIMER'S PLATFORM FOUNDATION (GAP) WORKS WITH INTERNATIONAL ORGANIZATIONS THAT SHARE OUR GOALS FOR CLINICAL TRIAL INNOVATION. GAP REGULARLY ENGAGES WITH GLOBAL PARTNERS TO COORDINATE EFFORTS, SHARE INFORMATION AND MAINTAIN OPEN DIALOGUE WITH INITIATIVES UNDER DEVELOPMENT IN A NUMBER OF COUNTRIES AND CONTINENTS. false false 10235066 0 6213316 THE ORGANIZATION IS ESTABLISHING A STANDING GLOBAL TRIAL-READY PLATFORM TO DRIVE QUALITY, EFFICIENCY, AND INNOVATION IN ALZHEIMER'S CLINICAL TRIALS, SEEKING TO REDUCE CLINICAL TESTING CYCLE TIMES BY TWO YEARS AND TO ACHIEVE GREATER UNIFORMITY IN TRIAL POPULATIONS. IT IS DOING THAT BY BUILDING LARGE, WELL-CHARACTERIZED TRIAL-READY COHORTS, AND A NETWORK OF CERTIFIED HIGH-PERFORMANCE CLINICAL TRIAL SITES. 10235066 true true false false false false false false false false false false false true false false false false false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 42 0 true 60 true false false false false false false false false false false false false X 6 6 false false false false false false false true true false false true true true true true true true true false X THE ORGANIZATION 3014522111 1101 K STREET NW SUITE 400 WASHINGTON DC 20005 X LAMMERT ALBERS CHIEF COMMERCIAL OFFICER 40.0 0.0 X 659042 0 20416 JOHN R DWYER president 40.0 0.0 X 651044 0 22502 DANIEL G MARREN CHIEF FINANCIAL OFFICER 40.0 0.0 X 386454 0 21215 SUSAN J STEEN Medical Dir. & principal inv. 40.0 0.0 X 299535 0 10773 LEIGH K ZISKO CHIEF IMPACT OFFICER 40.0 0.0 X 281256 0 9516 JILL S SMITH SENIOR DIR OF gps OPERATIONS 40.0 0.0 X 200782 0 14881 JENNIFER L GAUDIOSO ASSOC DIR, CLINICAL OPERATIONS 40.0 0.0 X 164361 0 13310 GEORGE VRADENBURG CHAIR 20.0 0.0 X 0 0 0 DREW HOLZAPFEL BOARD MEMBER 5.0 0.0 X 0 0 0 STEVEN PAUL BOARD MEMBER 5.0 0.0 X 0 0 0 NEIL BUCKHOLTZ BOARD MEMBER 5.0 0.0 X 0 0 0 MICHAEL GLOSSERMAN BOARD MEMBER 5.0 0.0 X 0 0 0 PASCALE WITZ BOARD MEMBER 5.0 0.0 X 0 0 0 2642474 0 112613 22 false true false PINTAIL SOLUTIONS LLC 40 CRICKET KNOLL LANE CARMEL IN 46033 PROGRAM MANAGEMENT 906578 C2N Diagnostics LLC 2320 Sugarcone Road BALTIMORE MD 21209 diagnostics 414075 Q Squared Solutions LLC 4820 Emporor Blvd DURHAM NC 27703 CLINICAL LABORATORY 377030 Lynne Hughes Consulting Ltd 5 RYE CLOSE BRACKNELL BERKSHIRE UK RG122QY clinical consulting 304972 ClinCloud LLC 1551 Sandspur Road MAITLAND FL 32751 cLINICAL TRIALS 303501 15 308735 308735 CLINICAL TRIALS 900099 6213316 6213316 6213316 57 57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 REBATES & REWARDS 900099 18110 18110 MISC REVENUE 900099 205 205 18315 6540423 6231631 0 57 X 21382 21382 0 0 0 1081215 1081215 0 2228800 2228800 0 240441 240441 231795 231795 0 118998 118998 26448 26448 0 0 0 4694111 4349849 344262 344829 344829 170283 170283 253606 253606 0 0 515555 515555 0 569870 569870 11433 11433 7840 7840 0 62722 62722 10579328 10235066 344262 0 X 369942 364893 625009 700011 0 0 558227 984144 0 0 0 0 0 0 0 0 833277 518260 0 0 0 0 0 0 0 0 0 0 1860735 975710 4247190 3543018 835651 795413 0 0 0 3374971 0 0 0 0 0 0 0 0 0 0 0 0 835651 4170384 X 3411539 -627366 0 0 3411539 -627366 4247190 3543018 -4038905 X false false false X UNIVERSITY OF KANSAS MEDICAL CENTER KANSAS KS DIGNITY HEALTH - ST JOSEPH'S HOSPITAL & MED PHOENIX AZ WASHINGTON UNIVERSITY MEDICAL CENTER ST LOUIS MO INDIANA UNIVERSITY MEDICAL CENTER INDIANAPOLIS IN BRIGHAM AND WOMEN'S HOSPITAL BOSTON MA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED INTERCOMPANY RECEIVABLE 974738 OTHER RECEIVABLE 972 975710 X X X false false false false false false false false false LAMMERT ALBERS CHIEF COMMERCIAL OFFICER 659042 0 0 0 0 0 10350 0 10066 0 679458 0 0 0 DANIEL G MARREN CHIEF FINANCIAL OFFICER 386454 0 0 0 0 0 10350 0 10865 0 407669 0 0 0 LEIGH K ZISKO CHIEF IMPACT OFFICER 281256 0 0 0 0 0 8438 0 1078 0 290772 0 0 0 JILL S SMITH SENIOR DIR OF gps OPERATIONS 200782 0 0 0 0 0 6082 0 8799 0 215663 0 0 0 JOHN R DWYER president 651044 0 0 0 0 0 10350 0 12152 0 673546 0 0 0 SUSAN J STEEN Medical Dir. & principal inv. 299535 0 0 0 0 0 9003 0 1770 0 310308 0 0 0 JENNIFER L GAUDIOSO ASSOC DIR, CLINICAL OPERATIONS 164361 0 0 0 0 0 5040 0 8270 0 177671 0 0 0 Schedule J, Part I, line 3: THE BOARD HAS A COMPENSATION COMMITTEE THAT MEETS TO REVIEW AND APPROVE COMPENSATION POLICIES AND COMPENSATION PLANS FOR OFFICERS. OFFICER COMPENSATION PLANS ARE REVIEWED AND COMPARED TO COMPARABLE MARKET DATA, ENVIRONMENTAL CONDITIONS AND OTHER IMPACTFUL CRITERIA. form 990, Part VI, Line 11: THE FORM 990 WAS REVIEWED BY ONE OF THE DIRECTORS AND CHIEF EXECUTIVE OFFICER. A COPY WAS PROVIDED TO THE ORGANIZATION'S GOVERNING BODY BEFORE IT WAS FILED WITH THE IRS. form 990, Part VI, Line 12c: EACH DIRECTOR, PRINCIPAL OFFICER AND MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS ANNUALLY SIGNS A STATEMENT WHICH AFFIRMS THAT EACH HAS 1) RECEIVIED A COPY OF THE CONFLICTS OF INTEREST POLICY; 2) HAS READ AND UNDERSTANDS THE POLICY; 3) HAS AGREED TO COMPLY WITH THE POLICY; AND LASTLY, UNDERSTANDS THAT THE ORGANIZATION IS A NON-PROFIT PUBLIC BENEFIT CORPORATION AND, IN ORDER TO MAINTAIN ITS FEDERAL EXEMPTION, IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. form 990, Part VI, Line 15a and 15b: THE BOARD HAS A COMPENSATION COMMITTEE THAT MEETS TO REVIEW AND APPROVE COMPENSATION POLICIES AND COMPENSATION PLANS FOR OFFICERS. OFFICER COMPENSATION PLANS ARE REVIEWED AND COMPARED TO COMPARABLE MARKET DATA, ENVIRONMENTAL CONDITIONS AND OTHER IMPACTFUL CRITERIA. form 990, Part VI, line 18: THE ORGANIZATION ALLOWS FOR NORMAL REVIEW OF ITS FORM 990 DURING NORMAL BUSINESS HOURS. form 990, Part VI, line 19: THE ORGANIZATION MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990 PART IX LINE 11G DESCRIPTION:TRIAL SERVICES TOTAL FEES:2744571 FORM 990 PART IX LINE 11G DESCRIPTION:CONTRACTED SERVICES TOTAL FEES:1368454 FORM 990 PART IX LINE 11G DESCRIPTION:CONSULTING SERVICE TOTAL FEES:447943 FORM 990 PART IX LINE 11G DESCRIPTION:PAYROLL PROCESSING TOTAL FEES:100509 FORM 990 PART IX LINE 11G DESCRIPTION:OTHER SERVICES TOTAL FEES:32634 GAP Innovations PBC Clinical Trials DE GAPF INC C CORP. 3945234 15327357 1.00000 AXIOM BRAIN HEALTH LLC Clin. Trials Site DE GAP Innovations C CORP. 1214955 1164619 1.00000 false false false false false false false false false false false false true false true false true true true GAP Innovations L 68944 CASH GAP Innovations O 2930402 CASH GAP Innovations R 300000 CASH GAP Innovations S 4474999 CASH AXIOM BRAIN HEALTH O 1383476 CASH AXIOM BRAIN HEALTH Q 116308 CASH AXIOM BRAIN HEALTH S 1210129 CASH